Please visit the COVID-19 response page for resources and advice on managing through the crisis today and beyond.
To ensure patient safety, minimize costs and assure compliance, life sciences firms must aggressively detect and manage emerging safety risks.
Cognizant’s latest digital solutions enable long-term success. Our consultants address evolving issues related to drug safety and process consistency—such as global compliance requirements—and can integrate safety data from disparate sources. We also help you explore your options using digital advancements such as artificial intelligence (AI), analytics, blockchain and the cloud.
Cognizant’s IT and business consulting services are tailored specifically to your needs. Based on the latest digital technology and years of experience working with drug safety rules and regulations, our team can help you identify gaps in your pharmacovigilance processes and help you to implement strategies to resolve them.
Our business consulting services include:
Together with industry leaders Oracle, Medidata and Relsys, Cognizant can help you find the most appropriate commercial off-the-shelf (COTS) and custom digital solutions across the entire product safety value chain.
Cognizant’s solution accelerators are valuable in driving results quickly. Below is a partial list of prebuilt frameworks we provide:
Our other platform solutions include:
Stay on top of what's happening across Cognizant.
Come out and meet us at these upcoming events.